Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 4.2 USD 0.48% Market Closed
Market Cap: 4.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Portage Biotech Inc

Current Assets 5.2m
Cash & Short-Term Investments 3.3m
Receivables 86k
Other Current Assets 1.8m
Non-Current Assets 41k
PP&E 27k
Other Non-Current Assets 14k
Current Liabilities 3m
Accounts Payable 1.5m
Accrued Liabilities 1.3m
Other Current Liabilities 211k
Non-Current Liabilities -279k
Other Non-Current Liabilities -279k

Balance Sheet
Portage Biotech Inc

Rotate your device to view
Balance Sheet
Currency: USD
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
2
5
0
8
6
3
3
23
11
5
Cash
2
5
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
0
8
6
3
3
23
11
5
Short-Term Investments
0
0
59
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
1
1
0
1
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
2
1
2
3
Total Current Assets
2
5
59
8
7
4
5
25
14
8
PP&E Net
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
4
0
0
117
117
117
117
82
0
Goodwill
3
3
0
0
43
43
43
43
0
0
Note Receivable
0
0
0
1
0
0
0
0
0
0
Long-Term Investments
0
1
1
1
6
9
9
9
3
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
1
0
Other Assets
3
3
0
0
43
43
43
43
0
0
Total Assets
5
N/A
13
+168%
60
+375%
10
-83%
174
+1 637%
173
0%
175
+1%
195
+11%
99
-49%
8
-92%
Liabilities
Accounts Payable
1
0
0
0
1
1
0
0
0
3
Accrued Liabilities
0
0
0
0
0
0
0
0
2
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
1
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
1
3
0
0
0
Total Current Liabilities
1
0
0
0
2
3
3
1
2
3
Long-Term Debt
0
0
0
0
3
3
0
0
0
0
Deferred Income Tax
0
0
0
0
20
22
24
28
11
0
Minority Interest
2
2
0
0
49
49
46
44
1
1
Other Liabilities
0
0
0
0
0
0
0
0
11
2
Total Liabilities
2
N/A
2
+14%
0
-88%
0
+33%
74
+18 400%
77
+4%
73
-4%
74
+0%
23
-69%
4
-84%
Equity
Common Stock
10
17
18
24
116
118
131
158
219
219
Retained Earnings
7
7
17
14
17
22
30
38
138
215
Other Equity
0
0
25
0
0
1
1
1
4
0
Total Equity
3
N/A
10
+281%
60
+479%
10
-84%
100
+939%
97
-3%
101
+5%
121
+20%
76
-37%
4
-95%
Total Liabilities & Equity
5
N/A
13
+168%
60
+375%
10
-83%
174
+1 637%
173
0%
175
+1%
195
+11%
99
-49%
8
-92%
Shares Outstanding
Common Shares Outstanding
2
3
3
3
11
11
12
13
18
1

See Also

Discover More